Document is current

Article History

Received: 21 June 2023

Accepted: 17 August 2023

First Online: 30 September 2023

Declarations

:

: The PIN Questionnaire is a modified version of the VAPI Sanofi Pasteur, 2009 All Rights Reserved. VAPI contact information and permission to use: Mapi Research Trust, Lyon, France. Email: PROinformation@mapi-trust.org—internet: . Dominy Browning and Christina Donatti are employees of ViiV Healthcare and may own stocks/shares in GSK. Vasiliki Chounta (current affiliation: none) was an employee of ViiV Healthcare at the time of the study and may own stocks/shares in GSK. Jeremy Lambert (current affiliation: UCB Pharma, Colombes, France), Mickael Henry-Szatkowski (current affiliation: IQVIA, Patient Centered Solution, Paris, France), and Hilary F. Byrnes were employees at the time the study was conducted of ICON plc which was paid to conduct the project.

: This post hoc psychometric analysis was conducted on anonymous data and no direct participant contact or primary collection of individual human participant data occurred. Study results are in tabular form and aggregate analyses that omit participant identification, therefore informed consent or ethics committee or IRB approval were not required. The PRO data used in this analysis were a secondary endpoint in two clinical trials: ATLAS and FLAIR, both of which were conducted in accordance with the principles founded in the Declaration of Helsinki and with Good Clinical Practice. The ATLAS and FLAIR protocols were approved by an institutional review board or ethics committee of each study site. All participants provided written informed consent to participate in the clinical trials and any subsequent analysis of the data as it was derived from those clinical trials.